65 related articles for article (PubMed ID: 7492439)
21. Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.
Harris SJ; Gearing AJ; Layton GT; Adams SE; Kingsman AJ
Immunology; 1992 Nov; 77(3):315-21. PubMed ID: 1362183
[TBL] [Abstract][Full Text] [Related]
22. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
[TBL] [Abstract][Full Text] [Related]
23. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
24. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
Bhowmick S; Mazumdar T; Sinha R; Ali N
J Control Release; 2010 Jan; 141(2):199-207. PubMed ID: 19818373
[TBL] [Abstract][Full Text] [Related]
25. Liposomal cytokines and liposomes targeted to costimulatory molecules as adjuvants for human immunodeficiency virus subunit vaccines.
Ozpolat B; Lachman LB
Methods Enzymol; 2003; 373():92-100. PubMed ID: 14714398
[No Abstract] [Full Text] [Related]
26. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
McCormick AL; Thomas MS; Heath AW
J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant action of murine IL-2/Ig plasmid after intramuscular immunization with Indian HIV-1 subtype C recombinant env.gp 120 construct.
Aggarwal P; Kumar S; Vajpayee M; Seth P
Viral Immunol; 2005; 18(4):649-56. PubMed ID: 16359231
[TBL] [Abstract][Full Text] [Related]
28. HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.
Gorse GJ; Patel GB; Belshe RB;
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1175-89. PubMed ID: 11522187
[TBL] [Abstract][Full Text] [Related]
29. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
30. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
31. Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin.
Mu HH; Sewell WA
Immunology; 1994 Dec; 83(4):639-45. PubMed ID: 7875744
[TBL] [Abstract][Full Text] [Related]
32. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity.
Li L; Elliott JF; Mosmann TR
J Immunol; 1994 Nov; 153(9):3967-78. PubMed ID: 7930605
[TBL] [Abstract][Full Text] [Related]
33. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine.
Takeda S; Shiosaki K; Kaneda Y; Nakasatomi T; Yoshizaki H; Someya K; Konno Y; Eda Y; Kino Y; Yamamoto N; Honda M
Clin Immunol; 2004 Jul; 112(1):92-105. PubMed ID: 15207786
[TBL] [Abstract][Full Text] [Related]
34. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
Staats HF; Nichols WG; Palker TJ
J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
[TBL] [Abstract][Full Text] [Related]
35. Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.
Kim M; Qiao ZS; Montefiori DC; Haynes BF; Reinherz EL; Liao HX
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):58-67. PubMed ID: 15665645
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
McFarland EJ; Borkowsky W; Fenton T; Wara D; McNamara J; Samson P; Kang M; Mofenson L; Cunningham C; Duliege AM; Sinangil F; Spector SA; Jimenez E; Bryson Y; Burchett S; Frenkel LM; Yogev R; Gigliotti F; Luzuriaga K; Livingston RA;
J Infect Dis; 2001 Nov; 184(10):1331-5. PubMed ID: 11679925
[TBL] [Abstract][Full Text] [Related]
37. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants.
Bomford R; Stapleton M; Winsor S; McKnight A; Andronova T
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1765-71. PubMed ID: 1457190
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.
McFarland EJ; Johnson DC; Muresan P; Fenton T; Tomaras GD; McNamara J; Read JS; Douglas SD; Deville J; Gurwith M; Gurunathan S; Lambert JS
AIDS; 2006 Jul; 20(11):1481-9. PubMed ID: 16847402
[TBL] [Abstract][Full Text] [Related]
39. Non-natural glycosphingolipids and structurally simpler analogues bind HIV-1 recombinant Gp120.
McReynolds KD; Bhat A; Conboy JC; Saavedra SS; Gervay-Hague J
Bioorg Med Chem; 2002 Mar; 10(3):625-37. PubMed ID: 11814851
[TBL] [Abstract][Full Text] [Related]
40. AIDS vaccines and adjuvant formulations.
Cernescu CE
Int J Immunopharmacol; 1994; 16(5-6):369-79. PubMed ID: 7927981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]